Dr Christopher Grant Langendorf
Honorary (Fellow)
Department of Medicine
13 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
AMPK phosphosite profiling by label-free mass spectrometry reveals a multitude of mTORC1-regulated substrates
DOI: 10.1038/s44324-025-00052-72022
Journal article
A novel small molecule inhibitor of human Drp1
DOI: 10.1038/s41598-022-25464-z2022
Journal article
Structure-function analysis of the AMPK activator SC4 and identification of a potent pan AMPK activator
DOI: 10.1042/BCJ202200672021
Journal article
Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes
DOI: 10.1021/acs.jmedchem.0c022742021
Journal article
Post-translational modifications of the energy guardian amp-activated protein kinase
DOI: 10.3390/ijms220312292020
Journal article
Functional analysis of an R311C variant of Ca2 -calmodulin-dependent protein kinase kinase-2 (CaMKK2) found as a de novo mutation in a patient with bipolar disorder
DOI: 10.1111/bdi.129012020
Journal article
CaMKK2 is inactivated by cAMP-PKA signaling and 14-3-3 adaptor proteins
DOI: 10.1074/jbc.RA120.013756
RECENT SCHOLARLY WORKS
2020
Journal article
Long-chain fatty acyl-CoA esters regulate metabolism via allosteric control of AMPK β1 isoforms
DOI: 10.1038/s42255-020-0245-22020
Journal article
New perspectives on the role of Drp1 isoforms in regulating mitochondrial pathophysiology
DOI: 10.1016/j.pharmthera.2020.1075942018
Journal article
AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965
DOI: 10.1074/jbc.RA118.003547